LobnaAbdel SatIbrahimMD

PubMed

• A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
  Zarate CA, Mathews D, Ibrahim L, Chaves JF, Marquardt C, Ukoh I, Jolkovsky L, Brutsche NE, Smith MA, Luckenbaugh DA> ;Biol. Psychiatry. 2013-08-15
• Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
  Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Manji HK, Zarate CA, Drevets WC> ;Biol. Psychiatry. 2013-06-15
• 157 citations
  A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.
  Nancy Diazgranados, Libby Jolkovsky, Nancy E. Brutsche, David A. Luckenbaugh, W. Joseph Herring, William Z. Potter, Carlos A. Zarate> ;Journal of Clinical Psychopharmacology. 2012 Aug 1
• Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
  Zhao X, Venkata SLV, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, Zarate CA, Mager DE, Wainer IW> ;Br J Clin Pharmacol. 2012-08-01
• Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
  Zarate CA, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA> ;Biol. Psychiatry. 2012-06-01
• 223 citations
  Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled S...
  Nancy Diazgranados, Jose A. Franco-Chaves, Nancy E. Brutsche, Ioline D. Henter, Phillip Kronstein, Ruin Moaddel, Irving W. Wainer, David A. Luckenbaugh, Husseini K. Ma...> ;Neuropsychopharmacology. 2012 Feb 1
• An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
  Salvadore, G., van der Veen, J.W., Zhang, Y., Marenco, S., Machado-Vieira, R., Baumann, J., Ibrahim, L.A., Luckenbaugh, D.A., Shen, J., Drevets, W.C., Zarate, C.A.> ;Int J Neuropsychopharmacol. 2012 Sep
• Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
  DiazGranados, N., Ibrahim, L.A., Brutsche, N.E., Ameli, R., Henter, I.D., Luckenbaugh, D.A., Machado-Vieira, R., Zarate, C.A.> ;J Clin Psychiatry. 2010 Dec
• 918 citations
  A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression
  Nancy Diazgranados, Lobna Ibrahim, Nancy E. Brutsche, Andrew B. Newberg, Phillip Kronstein, Sami Khalife, William A. Kammerer, Zenaide M.N. Quezado, David A. Luckenbau...> ;Archives of General Psychiatry. 2010 Aug 1
• Novel glutamatergic agents for major depressive disorder and bipolar disorder.
  Machado-Vieira, R., Ibrahim, L., Henter, I. D., Zarate, C. A.> ;Pharmacol Biochem Behav. 2012 Feb
• Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions.
  Machado-Vieira, R., Ibrahim, L., Zarate, C. A.> ;CNS Neurosci Ther. 2011 Dec
• New therapeutic targets for mood disorders.
  Machado-Vieira, R., Salvadore, G., DiazGranados, N., Ibrahim, L., Latov, D., Wheeler-Castillo, C., Baumann, J., Henter, I. D., Zarate, C. A.> ;ScientificWorldJournal. 2010
• 36 citations
  Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.
  Wallace C. Duncan, David A. Luckenbaugh, Peixiong Yuan, Rodrigo Machado-Vieira, Carlos A. Zarate> ;Brain Research Bulletin. 2011 Aug 10
• Glutamatergic modulators: the future of treating mood disorders?
  Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., Salvadore, G.> ;Harv Rev Psychiatry. 2010 Oct 01
• 139 citations
  Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
  Nancy Diazgranados, David A. Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G. Mallinger, Carlos A. Zarate, Lobna Ibrahim> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 Jun 1
• Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.
  Machado-Vieira, R., Salvadore, G., Ibrahim, L. A., Diaz-Granados, N., Zarate, C. A.> ;Curr Pharm Des. 2009 May 16
• Join now to see all